AI tools designed to make health care more efficient are ubiquitous, though many remain piecemeal and siloed, as researchers ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...